337 results match your criteria: "Kirby Institute for Infection and Immunity[Affiliation]"
Prev Med
July 2023
Specialty of Child and Adolescent Health, Faculty of Medicine and Health, The University of Sydney, NSW, Australia; Wellbeing, Health and Youth National Health and Medical Research Council Centre for Research Excellence in Adolescent Health, Sydney, Australia.
Using a cluster-randomized trial design, we aimed to evaluate a complex intervention to increase uptake of human papillomavirus (HPV) vaccination in schools. The study was undertaken in high schools in Western Australia and South Australia between 2013 and 2015 with adolescents aged 12-13 years. Interventions included education, shared decision-making, and logistical strategies.
View Article and Find Full Text PDFImmunol Cell Biol
July 2023
The Kirby Institute for Infection and Immunity, UNSW Medicine, UNSW Sydney, Kensington Campus, Sydney, NSW, Australia.
Despite the widespread availability of effective prophylactic vaccines to prevent human papillomavirus (HPV) infection, HPV remains a major health burden. For health care systems in countries with the capacity for vaccine roll out, incomplete strategies result in citizens with naturally occurring infection, who are at an a posteriori risk of HPV-driven disease. Genital HPV infection is the most common sexually transmitted virus globally.
View Article and Find Full Text PDFGlob Public Health
January 2023
Centre for Social Research in Health, UNSW Sydney, Sydney, Australia.
Aboriginal and Torres Strait Islander (Aboriginal) young people seek information and access health services for their sexual health needs. This study examined Aboriginal young people's perspectives on sexual health services and sex education in Australia. Overall, 51 Aboriginal people aged 16-26 years were interviewed by peer researchers in Sydney, Australia in 2019-2020.
View Article and Find Full Text PDFLancet Gastroenterol Hepatol
June 2023
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; National Institute for Health Research Health Protection Research Unit in Behavioural Science and Evaluation, University of Bristol, Bristol, UK.
Background: Measuring the incidence of HIV and hepatitis C virus (HCV) infection among people who inject drugs (PWID) is key to track progress towards elimination. We aimed to summarise global data on HIV and primary HCV incidence among PWID and associations with age and sex or gender.
Methods: In this systematic review and meta-analysis, we updated an existing database of HIV and HCV incidence studies among PWID by searching MEDLINE, Embase, and PsycINFO, capturing studies published between Jan 1, 2000, and Dec 12, 2022, with no language or study design restrictions.
Lancet HIV
April 2023
Burnet Institute, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Centre for Sexual Health and HIV/AIDS Research (CeSHHAR), Harare, Zimbabwe; Liverpool School of Tropical Medicine, Liverpool, UK; International Centre for Re
Background: Despite proven benefits for child health, coverage of early infant diagnosis of HIV remains suboptimal in many settings. We aimed to assess the effect of a point-of-care early infant diagnosis test on time-to-results communication for infants vertically exposed to HIV.
Methods: This pragmatic, cluster-randomised, stepped-wedge, open-label trial assessed the effect of the Xpert HIV-1 Qual early infant diagnosis test (Cepheid) on time-to-results communication, compared with standard care laboratory-based testing of dried blood spots using PCR.
Viruses
February 2023
Serology and Virology Division (SAViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Australia experienced widespread COVID-19 outbreaks from infection with the SARS-CoV-2 Delta variant between June 2021 and February 2022. A 17-nucleotide frameshift-inducing deletion in ORF7a rapidly became represented at the consensus level (Delta-ORF7a) in most Australian outbreak cases. Studies from early in the COVID-19 pandemic suggest that frameshift-inducing deletions in ORF7a do not persist for long in the population; therefore, Delta-ORF7a genomes should have disappeared early in the Australian outbreak.
View Article and Find Full Text PDFJ Acquir Immune Defic Syndr
May 2023
The Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, Australia.
Background: Evidence regarding the characteristics of second primary cancer (SPC) in people living with HIV (PLWHIV) is limited.
Setting: We performed a national population-based data linkage study to determine the incidence and risk factors of SPC in PLWHIV in Australia between 1982 and 2012.
Methods: We conducted a probabilistic data linkage study to compare the incidence of SPC over time, defined using HIV treatment eras, for SPCs related to oncogenic viral infection in comparison with non-infection-related SPCs.
Vaccine
March 2023
Biosecurity Program, The Kirby Institute for Infection and Immunity, UNSW Sydney, Australia.
Background: Evidence has accrued that influenza vaccination may be effective in preventing myocardial infarction (MI). However, vaccination rates in both adults and health care workers (HCW) are low, and hospitalisation is often a missed opportunity for vaccination. We hypothesised that knowledge, attitude and practices of health care workers regarding vaccination impacts vaccine uptake in hospitals.
View Article and Find Full Text PDFAddiction
June 2023
Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
Background And Aims: Although the Netherlands, Canada and Australia were early adopters of harm reduction for people who inject drugs (PWID), their respective HIV and hepatitis C (HCV) epidemics differ. We measured the pooled effect of needle and syringe program (NSP) and opioid agonist therapy (OAT) participation on HIV and HCV incidence in these settings.
Design: For each cohort, we emulated the design and statistical analysis of a target trial using observational data.
Cult Health Sex
November 2023
Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Sydney, New South Wales, Australia.
For people living with HIV, decisions about when, how and who to tell about their HIV status can involve navigating complex social, legal and health domains. With a focus on disclosure to broader social and familial networks, we explored the experiences of, and motivations for, HIV (non-)disclosure among recently diagnosed people living with HIV in Australia. Semi-structured interviews were conducted with 35 people diagnosed with HIV from 2016 onwards, of whom 25 completed follow-up interviews.
View Article and Find Full Text PDFBMC Health Serv Res
December 2022
Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Wallace Wurth Building, UNSW Sydney, Kensington, NSW, 2052, Australia.
Background: A field trial to evaluate a self-collect point-of-care HPV screen-and-treat (HPV S&T) program was implemented in two Well Women Clinics in Papua New Guinea (Papua New Guinea). Assessing the acceptability of a health intervention is a core element of evaluation. In this study, we examined women's acceptability of both self-collection and HPV S&T intervention in Papua New Guinea.
View Article and Find Full Text PDFNat Commun
December 2022
School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
T cell exhaustion is a hallmark of hepatitis C virus (HCV) infection and limits protective immunity in chronic viral infections and cancer. Limited knowledge exists of the initial viral and immune dynamics that characterise exhaustion in humans. We studied longitudinal blood samples from a unique cohort of individuals with primary infection using single-cell multi-omics to identify the functions and phenotypes of HCV-specific CD8 T cells.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
December 2022
Department of Microbiology and Immunology, Cornell University, Ithaca, NY 14853.
PLoS One
November 2022
Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Kensington, Australia.
Background: Female sex workers (FSWs) in Uganda are at high risk of HIV infection. Scaling up oral pre-exposure prophylaxis (PrEP) will reduce HIV incidence if high levels of adherence are maintained. This study evaluates PrEP adherence using clinic-based pill counts and self-reported measures, and factors associated with protective levels of adherence.
View Article and Find Full Text PDFAm J Infect Control
November 2022
Emergency Department, Calvary Hospital 5 Mary Potter Cct, Bruce, ACT 2617, Australia; Emergency Medicine, Australian National University, Canberra, ACT 2600, Australia; Health & Design, University of Canberra, The Australian National University, Canberra, ACT 2600, Australia.
Diagnostics (Basel)
August 2022
The Queensland Paediatric Infectious Diseases (QPID) Research Group, Queensland Children's Hospital, Brisbane, QLD 4101, Australia.
The continuous transmission and evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has required that diagnostic capabilities be constantly monitored and updated as new variants emerge and prior variants disappear. Although whole genome sequencing provides full characterisation of SARS-CoV-2 directly from patient samples, this has limited throughput and requires sufficient resources. To enhance screening for circulating variants, we designed a rapid in-house RT-PCR assay to target a spike mutation (D950N) in Delta variants, which is not detected in the remaining variants of concern (VOCs).
View Article and Find Full Text PDFBackground: Little research has explored the sexual and reproductive health (SRH) experience of female sex workers (FSW), including girls aged < 18 years who are commercially sexually exploited (CSE), in Papua New Guinea (PNG). This paper describes the SRH history of FSW and CSE girls and factors associated with their use of moderately or highly effective contraceptive methods in three settings in PNG.
Methods: From 2016 to 2017, respondent-driven sampling (RDS) surveys were conducted among FSW and CSE girls in Port Moresby, Lae, and Mt.
Objective: To assess the prevalence, and factors associated with QTc interval prolongation, among 383 virologically suppressed people with HIV (PWH), without evidence of cardiovascular disease and active opportunistic infections in Thailand.
Design: Cross-sectional study.
Methods: Resting 12-lead digital ECGs were performed in 2019.
Lancet Glob Health
September 2022
Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Kensington, NSW, Australia.
Background: WHO recommends human papillomavirus (HPV) testing and same-day treatment for cervical screening in low-income and middle-income countries (LMICs); however, few published data exist on the validity of the strategy. We aimed to evaluate the clinical performance, treatment completion rates, adverse events profile, and acceptability of a fully integrated strategy, comprising point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation, for screening of cervical cancer in women in Papua New Guinea.
Methods: HPV-STAT was a large-scale, prospective, single-arm intervention trial conducted at two clinical sites in Papua New Guinea.
BMJ Glob Health
July 2022
Centre for Social Research in Health, UNSW Sydney, Sydney, New South Wales, Australia.
Introduction: Aboriginal and Torres Strait Islander (Aboriginal) people compared with non-Aboriginal people in Australia have higher rates of chronic conditions. These conditions increase the risk of poorer health outcomes if infected with COVID-19, highlighting the importance of COVID-19 vaccination. This study examined what Aboriginal people think about COVID-19 vaccines, reasons why they were vaccinated or not vaccinated and factors involved in receiving COVID-19 vaccination.
View Article and Find Full Text PDFAddiction
December 2022
Behaviours and Health Risks, Burnet Institute, Melbourne, VIC, Australia.
Aims: To measure mortality rates and factors associated with mortality risk among participants in the SuperMIX study, a prospective cohort study of people who inject drugs.
Design: A prospective observational study using self-reported behavioural and linked mortality data.
Setting: Melbourne, Australia.
J Med Virol
September 2022
Department of Microbiology and Infectious Diseases, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Pathology
June 2022
Department of Microbiology and Infectious Diseases, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Sex Transm Infect
May 2022
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
Objective: To examine associations between infection during pregnancy and adverse outcomes.
Methods: We did a systematic review of observational studies. We searched Medline, EMBASE, the Cochrane Library and CINAHL up to 11 August 2021.
Am J Public Health
April 2022
Jade Boyd and Thomas Kerr are with the Department of Medicine, University of British Columbia, Vancouver, BC, Canada. Lisa Maher is with the Kirby Institute for Infection and Immunity, Faculty of Medicine, University of New South Wales, Sydney, Australia. Tamar Austin and Jennifer Lavalley are with
To identify key gaps in overdose prevention interventions for mothers who use drugs and the paradoxical impact of institutional practices that can increase overdose risk in the context of punitive drug policies and a toxic drug supply. Semistructured interviews were conducted with 40 women accessing 2 women-only, low-barrier supervised consumption sites in Greater Vancouver, British Columbia, Canada, between 2017 and 2019. Our analysis drew on intersectional understandings of structural, everyday, and symbolic violence.
View Article and Find Full Text PDF